CSM Technologies' IPO is seeing a subdued response on its second day, with only 32% subscription. Retail investors show more interest, subs...

Tata Sons faces renewed scrutiny after RBI tightened rules for upper-layer NBFCs, reinforcing pressure for mandatory listings above Rs 1 la...

Avience Biomedicals made a spectacular debut on the NSE SME platform, with its shares rocketing 90% on listing day. The Rs 30.24 crore IPO,...

SK Hynix shares surged as much as 12% after the memory chipmaker unveiled plans for a $29 billion US listing, boosting hopes of higher valu...

South Korea's SK Hynix is planning a record-breaking secondary listing on the U.S. stock market, aiming to raise up to $29.4 billion. This ...

Leapfrog Engineering Services experienced a subdued market entry, with its shares listing at a 4.3% discount to the IPO price on the BSE SM...

Vedanta's demerger saw mixed fortunes for its listed entities. While Vedanta Power and Oil & Gas shares dipped, Vedanta Aluminium and Iron ...

The Rs 36.02-crore IPO received a subdued response from investors, with the issue being subscribed 1.91 times during the three-day bidding ...

Diksha Polymers debuted on the BSE SME platform at a slight premium, opening at Rs 114.50 against its IPO price of Rs 112. The Rs 17.9-cror...

Waterways Leisure Tourism IPO entered Day 2 with weak investor demand and a GMP of around 1%, signalling a flat listing outlook. Subscripti...

The Rs 26.73-crore IPO is entirely a fresh issue of 27 lakh equity shares and will remain open for subscription till June 29

The Rs 110.11-crore NSE SME IPO was subscribed 103.06 times during the three-day bidding period, led by strong demand from non-institutiona...

The NSE SME issue will remain open for bidding till June 25. The company aims to raise Rs 30.68 crore through an entirely fresh issue of 57...

The BSE SME issue closed on June 25, while the shares are scheduled to list on July 1. The IPO is priced at Rs 196 per share and comprises ...

Fixed dose combination banned full list: India has banned 16 fixed-dose combination drugs, including certain antibiotics and antispasmodics...

As NSE prepares for its massive IPO, its DRHP reveals it significantly outperforms BSE in key trading metrics despite having fewer listed c...

If the grey market trend holds through listing, the stock could open with gains in that range, continuing the trend of strong debuts seen a...